BRAIN Biotech Future Growth
Future criteria checks 5/6
BRAIN Biotech is forecast to grow earnings and revenue by 65.4% and 12.4% per annum respectively. EPS is expected to grow by 63.7% per annum. Return on equity is forecast to be 27.3% in 3 years.
Key information
65.4%
Earnings growth rate
63.7%
EPS growth rate
| Chemicals earnings growth | 34.2% |
| Revenue growth rate | 12.4% |
| Future return on equity | 27.3% |
| Analyst coverage | Low |
| Last updated | 20 Mar 2024 |
Recent future growth updates
Recent updates
BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate
Apr 19
BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable
Mar 28Is BRAIN Biotech (ETR:BNN) A Risky Investment?
Feb 16Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt
Sep 13Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like
Mar 21Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?
Feb 14When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?
Jan 18How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?
Dec 31
Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?
Dec 10Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?
Nov 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2026 | 79 | 2 | 1 | 4 | 3 |
| 9/30/2025 | 76 | -3 | -1 | 2 | 4 |
| 9/30/2024 | 65 | -6 | -2 | 1 | 4 |
| 12/31/2023 | 55 | -8 | -7 | -5 | N/A |
| 9/30/2023 | 56 | -8 | -7 | -4 | N/A |
| 6/30/2023 | 55 | -7 | -11 | -5 | N/A |
| 3/31/2023 | 54 | -7 | -11 | -6 | N/A |
| 12/31/2022 | 54 | -7 | -9 | -3 | N/A |
| 9/30/2022 | 50 | -7 | -8 | -1 | N/A |
| 6/30/2022 | 48 | -8 | -3 | -2 | N/A |
| 3/31/2022 | 44 | -8 | -4 | -1 | N/A |
| 12/31/2021 | 41 | -4 | -3 | -2 | N/A |
| 9/30/2021 | 39 | -5 | -5 | -4 | N/A |
| 6/30/2021 | 37 | -6 | -5 | -2 | N/A |
| 3/31/2021 | 37 | -6 | -6 | -5 | N/A |
| 12/31/2020 | 37 | -11 | -9 | -6 | N/A |
| 9/30/2020 | 39 | -10 | -8 | -5 | N/A |
| 6/30/2020 | 41 | -9 | -11 | -4 | N/A |
| 3/31/2020 | 41 | -12 | -11 | -5 | N/A |
| 12/31/2019 | 41 | -12 | -10 | -4 | N/A |
| 9/30/2019 | 40 | -11 | -10 | -3 | N/A |
| 6/30/2019 | 39 | -9 | -5 | -4 | N/A |
| 3/31/2019 | 37 | -7 | -9 | -5 | N/A |
| 12/31/2018 | 33 | -7 | -8 | -7 | N/A |
| 9/30/2018 | 29 | -8 | -7 | -5 | N/A |
| 6/30/2018 | 27 | -9 | -9 | -8 | N/A |
| 3/31/2018 | 25 | -8 | -7 | -6 | N/A |
| 12/31/2017 | 26 | -7 | -6 | -4 | N/A |
| 9/30/2017 | 26 | -10 | N/A | -6 | N/A |
| 6/30/2017 | 26 | -14 | N/A | -6 | N/A |
| 3/31/2017 | 26 | -14 | N/A | -6 | N/A |
| 12/31/2016 | 25 | -17 | N/A | -6 | N/A |
| 9/30/2016 | 25 | -15 | N/A | -9 | N/A |
| 6/30/2016 | 24 | -10 | N/A | -8 | N/A |
| 3/31/2016 | 24 | -9 | N/A | -6 | N/A |
| 12/31/2015 | 24 | -7 | N/A | -5 | N/A |
| 9/30/2015 | 24 | -6 | N/A | -4 | N/A |
| 9/30/2014 | 13 | -5 | N/A | -4 | N/A |
| 9/30/2013 | 10 | -4 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BNN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: BNN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BNN is expected to become profitable in the next 3 years.
Revenue vs Market: BNN's revenue (12.4% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: BNN's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BNN's Return on Equity is forecast to be high in 3 years time (27.3%)